Bruker | BRKR - Equity Capital And Reserves


Bruker reported $2.44B in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
ABB USD 16.4B 1.04B Jun/2026
Agilent USD 7.36B 241M Jun/2026
Ametek USD 11.26B 341.47M Jun/2026
Bio Techne USD 2.11B 22.92M Jun/2026
Bio-Rad Laboratories USD 7.17B 322.6M Jun/2026
Bruker USD 2.44B 67M Jun/2026
Charles River Laboratories USD 2.84B 59.06M Jun/2026
Danaher USD 52.58B 368M Jun/2026
Fujikura JPY 608.6B 48.23B Jun/2026
Furukawa JPY 160.9B 10.7B Jun/2026
General Electric Aerospace USD 17.64B 417M Jun/2026
Hitachi JPY 6.57T 5.39B Jun/2026
Illumina USD 2.84B 162M Jun/2026
IQVIA Holdings USD 6.17B 50M Jun/2026
Mettler Toledo International USD 12.82M 54.71M Jun/2026
Mitsubishi Electric JPY 4.57T 58.44B Jun/2026
Mitsubishi Heavy Industries JPY 3.17T 82.67B Jun/2026
Myriad Genetics USD 303.9M 33.5M Jun/2026
Nikon Corporation JPY 593.36B 6.58B Jun/2026
Olympus JPY 747.9B 64.14B Jun/2026
Repligen USD 2.11B 6.57M Jun/2026
Revvity USD 7.18B 67.62M Mar/2026
Smiths GBP 2.58B 926M Dec/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Waters USD 15.29B 12.73B Mar/2026